Screener

Gain from sale of priority review voucher

Name: Krystal Biotech, Inc. Gain from sale of priority review voucher by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Krystal Biotech, Inc.·Business Segments·1 segment·Rolls up to Gain (loss) on disposal of assets

Breakdown

Segment	FY'25
Business Segments	$0
Total	$0

All segment values are derived from annual filings.

Segments

Business SegmentsView metric